Literature DB >> 14997039

Persistence of MHC DR nonexpression on swine cells by introduction of a mutated MHC class II transactivator gene: a comparison with the effect induced by antisense RNA.

Qishui Ou1, Lin Lin, Lidong Huang, Fuxiang Chen, Kegui Wu, Peihua Lu, Jingwu Zhang, Kuang-Yen Chou.   

Abstract

CIITA (class II transactivator) is a coactivator essential for transcription of MHC class II genes. In this study, a construct with a mutated CIITA gene with N-terminal domains depleted was constructed. This mutated CIITA (mCIITA) was able to repress DR and DQ expression in 45.0-60.0% of the mCIITA-transfected clones of swine endothelial cell line PIEC and in B cell line L23, as well as in human cell lines HeLa and Raji. Similarly, 30.0-46.7% of swine cell clones containing the human CIITA antisense RNA also failed to express DR molecules. However, the persistence of the DR repression on the cell lines is quite different. Transfection with mCIITA was persistent for at least 120 days, while with the CIITA antisense RNA, persistence existed for only 35-45 days. To explore the underlying mechanism, Raji cells were transfected with pUHD10-3-mCIITA, a mCIITA-containing, doxycycline-dependent plasmid. The intensity of DR repression is correlated quite well with the efficiencies of the mCIITA expression within the cells in a doxycycline dose-dependent manner. This implicates a competition between the mCIITA and its endogenous full-length counterpart. In addition, we were able to show that purified human CD4 T cells did not respond to the mCIITA-transfected PIECs in xenogeneic mixed lymphocyte endothelial reaction (MLER). The stimulating indices (SI) were only 1.0-1.5, compared with 15.2-18.2 for those transfected with empty vector or an initiation codon-depleted mCIITA that is dysfunctional for protein translation. The results we obtained, especially those for persistent suppression of class II genes, show promise for the possible development of mCIITA-transgenic swine for organ/tissue xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997039     DOI: 10.1023/B:JOCI.0000018068.37899.6d

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  Xenotransplantation. Cloned pigs may help overcome rejection.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2002-01-04       Impact factor: 47.728

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Direct human T-cell anti-pig xenoresponses are vigorous but significantly weaker than direct alloresponses.

Authors:  A Dorling; R Binns; R I Lechler
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

5.  Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal class II transactivator deletion mutants.

Authors:  K C Chin; G Li; J P Ting
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

6.  Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA.

Authors:  S J Gobin; A Peijnenburg; V Keijsers; P J van den Elsen
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

7.  Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.

Authors:  T Yazawa; H Kamma; M Fujiwara; M Matsui; H Horiguchi; H Satoh; M Fujimoto; K Yokoyama; T Ogata
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

8.  Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.

Authors:  Magda Dziembowska; Marie-Claude Fondaneche; Jocelyn Vedrenne; Giovanna Barbieri; Wojciech Wiszniewski; Capucine Picard; Andrew J Cant; Viktor Steimle; Dominique Charron; Catherine Alca-Loridan; Alain Fischer; Barbara Lisowska-Grospierre
Journal:  Immunogenetics       Date:  2002-01-29       Impact factor: 2.846

9.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

Authors:  V Steimle; C A Siegrist; A Mottet; B Lisowska-Grospierre; B Mach
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

10.  Class II transactivator regulates the expression of multiple genes involved in antigen presentation.

Authors:  C H Chang; R A Flavell
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  1 in total

1.  Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation.

Authors:  Zhiqiang Yang; Peng Gu; Xiaoyi Shao; Zuoqing Li; Yun Zhou; Liming Lu; Kuang-Yen Chou
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.